INTS

Conviction 28HealthcareScan · Mon, Aug 10, 2026

Bullish harami

INTS$4.25+2.16%

ResistanceSupportVol 14

Vol MA14 25.82K

May 11May 28Jun 16Jul 6Jul 23Aug 10

INTENSITY THERAPEUTICS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.intensitytherapeutics.com ↗

Price4.25

Change+2.16%

Gap+0.72%

Rel volume0.57×

Avg volume26.39K

Avg $ vol116.06K

SMA 204.43

SMA 504.26

SMA 2003.24

Price vs 50-0.14%

Price vs 200+31.08%

MA stackmixed

50/200 cross—

Supertrenddown · 4.94

RSI (14)46

MACD hist-0.03

MACD cross—

Stoch %K / %D44 / 32

ADX (14)17

+DI / −DI16 / 18

RSI divergence—

MACD divergence—

ATR %+5.93%

ADR %5.58%

52w high7.95

52w low0.2234

From 52w high-46.54%

Above 52w low+1802.42%

New 52w highNo

SqueezeOff

Bollinger width23.08%

%B0.32

Donchian pos25.65%

Donchian high4.99

Donchian low4.00

AVWAP (52w high)4.94

vs AVWAP high-13.90%

AVWAP (52w low)1.05

vs AVWAP low+305.40%

OBV trendDown

Chaikin MF (20)-0.11

Today vs 20d0.57×

Avg vol (14d)25.82K

Avg vol (20d)26.39K

Avg $ vol (20d)116.06K

Market cap11.49M

RS 3m (vs SPY)-24.29%

RS 6m (vs SPY)+1113.75%

RS line new highNo

Trend template5/8

Technical rank69.0

1 week-0.23%

1 month-11.09%

3 months-16.50%

6 months+1117.77%

1 year+1586.51%

YTD+944.23%

P/E-0.99

P/B1.15

P/S—

P/FCF—

EPS-8.56

Div yield—

ROE-116.30%

ROA-94.43%

Debt/Eq—

Current4.86

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth28.66%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.24M

Revenue—

Net income-2.43M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out2.7M

Employees7

ListedFri, Jun 30, 2023

Free float2.39M

Float %94.0%

Short interest162.6K

Days to cover3.0d

Short volume60.5%

Squeeze score42 / 100

Next earningsTue, Aug 11, 2026 · pre-mkt (1d)

EPS forecast−$0.81 · 1 est

Last EPS vs est−$0.96 vs −$1.35

Last surprise+28.9% beat

Setup gradeD

Conviction28 / 100

Pattern quality—

Tech rank69.0 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INTS

All disclosures →

No recent disclosed trades by Congress in INTS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in INTS

No recent insider (Form 4) filings in INTS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in INTS · 1 recent

EDGAR →

8-K8-KMaterial eventTue, Jun 16, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.